Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster

Formation and regional foundations

Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster appears in authority material dated 2025, and each named entity uses its corresponding public record.

The authority material uses the name Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster. A working review can begin with accelerator magnets and vacuum parts and accelerator integration and commissioning.

Core geography: Lanzhou, Wuwei and Lanzhou New Area

Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster operating-chain map

Six supply-and-demand connections in Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster

The links for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster show only a project-scoping sequence, moving from accelerator magnets and vacuum parts toward delivery conditions.

• accelerator magnets and vacuum parts — Before accelerator magnets and vacuum parts enter work for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster, confirm origin, specification, lot and substitution terms.
• accelerator integration and commissioning — Accelerator integration and commissioning for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster connect inputs and outputs, retaining revisions, stage results and responsibility at handoff.
• heavy-ion treatment systems — Heavy-ion treatment systems for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster are defined separately by specification, service scope and acceptance records.
• cancer hospitals — Cancer hospitals for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster have different use cases, so operating conditions should drive output and process requirements.
• radiation-safety licensing — Radiation-safety licensing guide acceptance for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster and stay linked to measurement, retesting and a lot or revision.
• shock-protected precision-part transport — Shock-protected precision-part transport link release, arrival, exception receipt and site handover for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

01 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Inputs and inbound terms

This chapter reviews input mix and inbound conditions for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

Work in Lanzhou uses accelerator magnets and vacuum parts, checks origin and lot before entry, and targets heavy-ion treatment systems.

Accelerator magnets and vacuum parts sample approval in Lanzhou should fix sampling, test conditions and acceptance limits together.

Accelerator magnets and vacuum parts in Lanzhou should carry the same lot or version trail through labels, packaging, transport and traceability records.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, grades, origin and substitution rules should be explicit.

02 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Operations and handoffs

This chapter reviews production stages and engineering interfaces for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

In Lanzhou, accelerator integration and commissioning lead to heavy-ion treatment systems, with process revisions and handoff responsibility recorded.

After accelerator integration and commissioning changes, reassess radiation-safety licensing and retain paired process versions and test results.

Before accelerator integration and commissioning in Lanzhou moves to heavy-ion treatment systems, use a sample or trial result to confirm the output boundary.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, equipment, software versions and accountable owners should be explicit.

03 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Outputs and acceptance

This chapter reviews output forms and acceptance measures for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

Heavy-ion treatment systems in Lanzhou serve cancer hospitals, with delivery scope separated by use.

Acceptance of heavy-ion treatment systems in Lanzhou should specify reproducible samples, methods, environments and decision rules.

Heavy-ion treatment systems are confirmed separately by registration or filing boundaries, specifications, lot records, storage and transport conditions, and user support.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, specifications, test environments and delivery documents should be explicit.

04 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Demand and purchasing

This chapter reviews demand side and purchasing routes for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

When cancer hospitals in Lanzhou purchase heavy-ion treatment systems, each use case needs separate confirmation.

Lanzhou can work back from the operating conditions of cancer hospitals to heavy-ion treatment systems, then test whether key parameters are repeatable.

An inquiry from cancer hospitals for heavy-ion treatment systems should state acceptance and delivery terms as well as volume and price.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, use case, volume range and acceptance owner should be explicit.

05 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Named entities

The three named entities for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster each link to their own public material.

Lanzhou Lanjinling Medical Technology Co., Ltd: R&D, registration and scaled production of nebulization, oxygen-delivery and intelligent dispensing devices.

Lanzhou Meihao Pharmaceutical Co., Ltd: Develops a Class I and II medical-device production project.

Lanzhou Taiji Ion Technology Co., Ltd: Construction, sales, commissioning and use of compact heavy-ion treatment systems.

• The three named entities for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster use only relationships directly stated in their own material.

06 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Quality and records

This chapter reviews quality review and technical files for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

Acceptance of heavy-ion treatment systems in Lanzhou starts with radiation-safety licensing, followed by measurement and retest methods.

If accelerator integration and commissioning in Lanzhou changes in process or version, reassess radiation-safety licensing instead of reusing the previous lot's conclusion.

After releasing heavy-ion treatment systems in Lanzhou, set retesting, exception-isolation and correction deadlines around radiation-safety licensing so responsibility remains traceable by lot or version.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, samples, test conditions and decision rules should be explicit.

07 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Delivery and site handover

This chapter reviews transport, delivery and site handover for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

Heavy-ion treatment systems in Lanzhou move through shock-protected precision-part transport, linking arrival with site responsibility.

When heavy-ion treatment systems in Gansu span lots, versions or service stages, every deliverable should link back to its record.

Delivery of heavy-ion treatment systems to cancer hospitals keeps packaging integrity, lot labels, storage temperature, transit time and arrival checks linked.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, packaging, temperature, humidity, shock protection and arrival checks should be explicit.

08 · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster: Engagement and due diligence

This chapter reviews engagement sequence and due-diligence list for Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster.

Before engaging around accelerator magnets and vacuum parts in Lanzhou, check the entity, standards, samples, price, lead time and support scope separately.

When checking entities including Lanzhou Lanjinling Medical Technology Co., Ltd, cluster designation does not prove performance; before quoting heavy-ion treatment systems, assign responsibility for radiation-safety licensing and shock-protected precision-part transport.

For an actual project serving cancer hospitals in Lanzhou, Wuwei and Lanzhou New Area, a small lot, sample or stage deliverable can test heavy-ion treatment systems before capacity, lead time and a longer engagement are discussed.

• Before Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster moves into execution, separate conclusions on regional designation and company capability should be explicit.

Sources and reading notes

Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster follows the name used in the authority material, records the three companies only by complete legal name and directly stated relationship, and leaves capacity, pricing and engagement terms for separate checks.

• Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster is the cluster name used in the 2025 authority material.
• The corresponding public record states this relationship for Lanzhou Lanjinling Medical Technology Co., Ltd: Lanzhou High-tech Zone | R&D, registration and scaled production of nebulization, oxygen-delivery and intelligent dispensing devices.
• The corresponding public record states this relationship for Lanzhou Meihao Pharmaceutical Co., Ltd: Zhongchuan Park, Lanzhou New Area | Develops a Class I and II medical-device production project.
• The corresponding public record states this relationship for Lanzhou Taiji Ion Technology Co., Ltd: Lanzhou New Area | Construction, sales, commissioning and use of compact heavy-ion treatment systems.

Related companies

These companies have a locally relevant industry role supported by public information. Order is not a ranking, inclusion does not imply authorization, partnership or endorsement, and Hello China does not participate in or guarantee transactions.

A company may request a free correction or removal through the formal channel if its record is inaccurate or it does not wish to be shown. Do not send business licences, authorization letters or other sensitive files through insecure channels.

• Lanzhou Lanjinling Medical Technology Co., Ltd. — Lanzhou Lanjinling Medical Technology Co., Ltd. · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster · Source: Lanjinling Medical-device Base Opens as Lanzhou High-tech Zone Supports Industrial Growth
• Lanzhou Meihao Pharmaceutical Co., Ltd. — Lanzhou Meihao Pharmaceutical Co., Ltd. · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster · Source: Lanzhou New Area Enterprise Investment Project Filings
• Lanzhou Taiji Ion Technology Co., Ltd. — Lanzhou Taiji Ion Technology Co., Ltd. · Lanzhou–Wuwei–Lanzhou New Area Nuclear Medicine and Medical Devices Cluster · Source: Publicity on Acceptance of the Environmental Report for Lanzhou Taiji Ion Technology’s Compact Heavy-ion Treatment System Project
• Request a company-record correction or removal — Requests are reviewed by a person, handled promptly after verification, free of charge and not tied to commercial cooperation.

Sources

Use the original publishers to check dates, scope and definitions; public material is not a transaction guarantee.

• Gansu Action Plan for Becoming a Major Destination for East-to-West Industrial Transfer — Gansu Provincial Department of Industry and Information Technology
• Lanjinling Medical-device Base Opens as Lanzhou High-tech Zone Supports Industrial Growth — Lanzhou High-tech Industrial Development Zone Administrative Committee
• Lanzhou New Area Enterprise Investment Project Filings — Lanzhou New Area Administrative Committee
• Publicity on Acceptance of the Environmental Report for Lanzhou Taiji Ion Technology’s Compact Heavy-ion Treatment System Project — Lanzhou New Area Administrative Committee
• Notice Issuing Gansu’s Action Plan for a National Regional Modern Manufacturing Base — People’s Government of Gansu Province
• Notice Issuing Gansu’s 15th Five-Year Plan for a Modern Industrial System — People’s Government of Gansu Province